Keyphrases
Rhabdomyosarcoma
100%
Craniofacial
66%
Survivors
56%
Head-and-neck
53%
Older Adults
35%
Patient Journey
33%
Facial Conditions
33%
Embryonal Rhabdomyosarcoma
26%
Proton Therapy
23%
Pediatric Radiology
23%
CLEFT-Q
20%
3D Imaging
20%
Facial Asymmetry
20%
Psychometric Properties
19%
Psychometric Validation
16%
Primary Tumor Size
16%
Facial Nerve Paralysis
16%
Vectra
16%
Orbital Bones
16%
Effect Analysis
16%
During Pregnancy
16%
Response Evaluation Criteria in Solid Tumors (RECIST)
16%
Dutch Population
16%
Magnetic Resonance Imaging
16%
Radiation Therapy
16%
Bone Morphology
16%
Medication Use
16%
Induction Chemotherapy
16%
Lactation
16%
Imaging Modalities
16%
Hearing Impairment
16%
Patient-reported Outcomes
16%
European Guidelines
16%
Dose Effect
16%
Early Change
16%
Rasch Measurement
15%
Theory Analysis
15%
Dutch
13%
Patient-Reported Outcomes Measurement Information System (PROMIS)
12%
Orbital Rhabdomyosarcoma
12%
Multidisciplinary Team
11%
Oncology
11%
Noncleft
11%
Local Control
10%
Facial Difference
10%
Orbital Socket
10%
Differential Item Functioning
9%
Alpha Value
8%
Cronbach's alpha
8%
Separation Index
8%
Medicine and Dentistry
Rhabdomyosarcoma
95%
Psychometry
38%
Neck
36%
Dose Response
33%
Radiation Therapy
33%
Rasch Analysis
29%
Embryonal Rhabdomyosarcoma
26%
Paediatric Radiology
23%
3D Imaging
23%
Proton Therapy
23%
Adverse Event
20%
Facial Nerve Paralysis
20%
Primary Tumor
16%
Cancer Staging
16%
Reproducibility
16%
Lactation
16%
Hearing Impairment
16%
Induction Chemotherapy
16%
Drug Therapy
16%
Magnetic Resonance Imaging
16%
Cleft
15%
Disease
11%
Oncology
11%
Pure Tone Audiometry
11%
Speech Production
11%
Patient-Reported Outcome
10%
Pediatrics
10%
Soft Tissue Sarcoma
10%
Face Deformity
10%
Clinical Assessment
10%
Checklist
9%
Childhood Cancer
8%
Skin Hemangioma
8%
Overall Survival
7%
Neoplasm
7%
Chemotherapy
7%
Contralateral
6%
Medicine
5%
Quality of Life
5%
Lip
5%
Jaw
5%
Logistic Regression Analysis
5%
Cochlea
5%
